According to a recent FiercePharma article, Sinovac Biotech has attracted a significant investment to increase manufacturing capacity for their Covid-19 vaccine. Sino Biopharmaceutical will pay $515 million for a 15.03% stake in Sinovac Life Sciences, a subsidiary of the vaccine specialist. The money will go directly to the development, manufacturing, and production capacity of their vaccine, CoronaVac.
Sinovac Gets Investment to Double Covid Vaccine Capacity
The Chinese pharmaceutical company raised over half a billion dollars to ramp up manufacturing.
Dec 11, 2020
Recommended
Recommended
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Downloads
